Takeda supports the pediatric transplant community

Takeda is a patient-focused, global biopharmaceutical company. We continue to seek new possibilities in transplantation, including potential treatment options to help address the unmet medical needs of transplant recipients with cytomegalovirus (CMV) infection.

*Contains information related to drugs under clinical development, which may not have yet received marketing authorization.

Pediatric Post-Transplant Cytomegalovirus Education

Cytomegalovirus Mechanism of Disease Video